Amicus Therapeutics Inc
NASDAQ:FOLD

Watchlist Manager
Amicus Therapeutics Inc Logo
Amicus Therapeutics Inc
NASDAQ:FOLD
Watchlist
Price: 9.455 USD -0.47%
Updated: May 17, 2024

Amicus Therapeutics Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amicus Therapeutics Inc
Tax Provision Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Amicus Therapeutics Inc
NASDAQ:FOLD
Tax Provision
-$6.6m
CAGR 3-Years
-20%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Tax Provision
-$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Gilead Sciences Inc
NASDAQ:GILD
Tax Provision
-$617m
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Tax Provision
-$582m
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Tax Provision
-$760.2m
CAGR 3-Years
-23%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Tax Provision
-$184.2m
CAGR 3-Years
22%
CAGR 5-Years
-4%
CAGR 10-Years
6%

See Also

What is Amicus Therapeutics Inc's Tax Provision?
Tax Provision
-6.6m USD

Based on the financial report for Mar 31, 2024, Amicus Therapeutics Inc's Tax Provision amounts to -6.6m USD.

What is Amicus Therapeutics Inc's Tax Provision growth rate?
Tax Provision CAGR 5Y
-35%

The average annual Tax Provision growth rates for Amicus Therapeutics Inc have been -20% over the past three years , -35% over the past five years .